CVD

Explore the complexities of CVD research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against CVD with flcube.com.

AstraZeneca to Invest USD 2 Billion in Summit Therapeutics – Clinical Collaboration Anchored on Ivonescimab and Claudin 18.2 ADC Sone‑Ve

Summit Therapeutics Inc. (NASDAQ: SMMT) announced an agreement with AstraZeneca plc (NYSE: AZN) under which AstraZeneca will make an equity investment of USD 2 billion in convertible preferred shares in…

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.